Community Letters

Sharing information for a stronger community

Read the latest updates and announcements from ITF Therapeutics.

March 2024

Update on development of DUVYZAT™ (givinostat) for treatment of DMD

+

March 2024

Actualización sobre el desarrollo de DUVYZAT™ (givinostat) para el tratamiento de la DMD

+

July 2024

ITF Therapeutics LLC announces commercial availability of DUVYZAT™ (givinostat) for the treatment of Duchenne muscular dystrophy

+

July 2024

ITF Therapeutics LLC anuncia la disponibilidad comercial de DUVYZAT™ (givinostat) para el tratamiento de la distrofia muscular de Duchenne

+

August 2025

An Exciting Update on the Long-Term Use of DUVYZAT®

+

September 2025

A Meaningful Milestone, Made Possible Together

+

October 2025

New data presented on DUVYZAT® (givinostat) at 2025 NMSG Annual Scientific Meeting

+